The global collagen derivatives market is securing a valuation of US$ 8,694.1 million in 2023 to US$ 15,865.2 million by 2033. Over the next ten years (2023 to 2033), global collagen derivatives sales are likely to soar at 6.2% CAGR.
Key Trends Listed by Future Market Insights (FMI):
Collagen derivatives are modified or processed forms of collagen, which are utilized in a whole lot of programs together with cosmetics, food and beverages, and prescription drugs. These derivatives are created with the aid of breaking down collagen into smaller fragments, editing its chemical shape, or combining it with other elements to decorate its houses.
Collagen derivatives are utilized in a huge variety of programs due to their unique properties that can encompass multiplied solubility, advanced texture, and enhanced nutritional cost. For example, collagen derivatives include hydrolyzed collagen peptides, which are normally used in cosmetics and skin care merchandise to enhance pores and skin hydration, elasticity, and a common look. It is used in the food and beverage industry as a gelatin, gelling agent, stabilizer, and emulsifier.
| Attributes | Key Insights |
|---|---|
| Estimated Global Collagen Derivatives Market Size (2023E) | US$ 8,694.1 million |
| Projected Collagen Derivatives Market Value (2033F) | US$ 15,865.2 million |
| Value-based CAGR (2023 to 2033) | 6.2% |
| Top 3 Countries’ Value Share | 34% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Market Statistics | Details |
|---|---|
| Jan to Jun (H1), 2021 (A) | 4.8% |
| Jul to Dec (H2), 2021 (A) | 4.5% |
| Jan to Jun (H1), 2022 Projected (P) | 5.7% |
| Jan to Jun (H1), 2022 Outlook (O) | 5.4% |
| Jul to Dec (H2), 2022 Outlook (O) | 6.7% |
| Jul to Dec (H2), 2022 Projected (P) | 6.3% |
| Jan to Jun (H1), 2023 Projected (P) | 5.7% |
| BPS Change: H1, 2022 (O) to H1, 2022 (P) | 31 |
| BPS Change: H1, 2022 (O) to H1, 2021 (A) | 55 |
| BPS Change: H2, 2022 (O) to H2, 2022 (P) | -35 |
| BPS Change: H2, 2022 (O) to H2, 2022 (A) | 117 |
As per Future Market Insights (FMI), The collagen derivatives have shown consistent growth, with a CAGR of 5.0% from 2018 to 2022. The market is expected to maintain this positive trend, with a projected CAGR of 6.2% over the 10 years.
Natural products have influenced customer preferences, the reason being the growing rate of consumers suffering from various diseases and being allergic to synthetic products. Manufacturers are increasingly offering naturally sourced products including collagen, especially for high-growth consumer product segments such as protein-oriented food products and nutraceutical products.
Consumers continue to express health-oriented concerns and are limiting the consumption of products that are perceived to have high levels of fat, calories, and sodium. The sales of healthier varieties should continue to rise, amid a health-conscious population.
Principal Consultant
| Region | North America |
|---|---|
| Country | United States |
| CAGR | 12.5% |
| BPS Analysis | 160 |
| Market Value (2033) | US$ 1,539.1 million |
| Region | Europe |
|---|---|
| Country | United Kingdom |
| CAGR | 4.7% |
| BPS Analysis | 120 |
| Market Value (2033) | US$ 593.0 million |
| Region | Asia Pacific |
|---|---|
| Country | China |
| CAGR | 8.7% |
| BPS Analysis | 110 |
| Market Value (2033) | US$ 795.1million |
| Region | Asia Pacific |
|---|---|
| Country | India |
| CAGR | 10.0% |
| BPS Analysis | 120 |
| Market Value (2033) | US$ 924.5 million |
| Region | Asia Pacific |
|---|---|
| Country | Japan |
| CAGR | 7.8% |
| BPS Analysis | 90 |
| Market Value (2033) | US$ 711.1 million |
Manufacturers offering innovative and diverse collagen derivatives in the United States
FMI's analysis indicates that the collagen derivatives industry in the United States is expected to grow at a compound annual growth rate of 12.5% during the assessment period. By 2023, the United States is projected to hold a dominant market share of 31.7%, showcasing a strong market presence in the collagen derivatives industry.
One of the key elements driving the growth of collagen derivatives within the United States is the increasing awareness of the advantages of collagen among consumers. Collagen derivatives are recognised to provide advantages inclusive of reducing joint aches, improving skin health, and lowering cartilage breakdown, which makes them an appealing element in nutraceutical merchandise.
The developing call for purposeful additives in food objects and the increasing adoption of Western ingesting habits also are riding the market boom. The United States is home to several manufacturers providing modern and numerous collagen derivatives, including satiety, muscle repair, weight loss, and electricity stability, creating monstrous boom possibilities within the marketplace.
Additionally, the United States is a mature marketplace for nutraceuticals, and the rising healthcare costs are influencing purchasers to pick out fitness supplements, similarly riding the marketplace growth. Overall, the rising reputation of collagen derivatives in nutraceutical merchandise is expected to force the boom of the United States marketplace in the coming years.
Increasingly Interest in Sustainable Products Elevating Collagen Derivatives Sales in Germany
According to Future Market Insights, the collagen derivatives market in the United Kingdom is expected to capture a valuation of approximately US$ 593.0 million by 2033, while the United Kingdom market is projected to grow at a CAGR of 4.7%.
The improvement of the latest and modern collagen-based total merchandise, along with fit-for-human consumption films, wound dressings, and tissue-engineering scaffolds, is growing new opportunities for the German collagen derivatives market.
It has a natural biomaterial, outstanding biocompatibility, low immunogenicity, and the capability to sell cell adhesion and tissue regeneration. Additionally, the growth of e-commerce channels has made collagen derivatives greater reachable to consumers, in particular in rising markets in which conventional retail channels may be confined in Germany.
Therefore, collagen derivatives in Germany are being driven by using a combination of factors, along with the developing call for practical food and dietary supplements, the getting old populace, the call for plant-based totally and sustainable alternatives, and the boom of the cosmetics enterprise.
Increasing preference for nutraceutical Supplements boosting the demand for collagen derivatives in India
As per the analysis of FMI, collagen derivatives demand in India is anticipated to rise at a steady CAGR of 10.0% during the forecast period from 2023 to 2033. By the end of 2033, India is likely to secure a valuation of US$ 924.5 million in the Asia Pacific region.
The Indian market for collagen derivatives is anticipated to witness great growth in demand in the coming years. This can be attributed to several factors, which include the increasing cognizance amongst consumers approximately the health blessings of collagen-based total products, the upward thrust of the nutraceutical enterprise in India
The nutraceutical enterprise in India is expected to be a main driver of the call for collagen derivatives, with the marketplace for nutritional supplements, useful foods, and useful beverages projected to develop rapidly in the coming years. Collagen is a vital factor in lots of these products because it has been proven to assist healthy joints, pores and skin, hair, and nails.
In addition to the nutraceutical industry, the cosmetics and private care enterprise in India is likewise predicted to drive the call for collagen derivatives. Collagen is a key aspect in lots of anti-getting older and pores and skin rejuvenation products because it allows for reducing the arrival of pleasant lines and wrinkles and improves pores and skin elasticity.
The increasing demand for natural and organic supplements is fuelling the growth of the powdered segment of the collagen derivatives market
As per Future Market Insights, the powder segment is projected to reach a valuation of US$ 695.2 million in 2033. The protein segment is poised to exhibit a CAGR of 6.3% during the assessment period of 2023 to 2033
The growing popularity of protein-rich diets, especially among athletes and fitness enthusiasts, is driving the demand for collagen derivatives in the powdered form. Collagen are known for their high protein content, which aids in muscle growth and recovery.
The availability of various flavors and formulations, such as unflavoured, fruit-flavoured, and chocolate-flavored collagen supplements, is attracting a wider consumer base and contributing to the growth of the market.
So, these driving factors are expected to continue to support the growth of the powdered form of collagen derivatives market shortly. as these supplements are perceived to be safer and healthier than synthetic supplements.
A versatile factor of nutraceuticals contributing to the increasing use of collagen derivatives
According to Future Market Insights, the nutraceutical segment is anticipated to thrive at 4.6% CAGR during the projection period. It will reach a market share of 27.4% in 2033.
Collagen derivatives possess unique properties that make them ideal for nutraceutical applications. Collagen peptides, derived from collagen through enzymatic hydrolysis, exhibit enhanced bioavailability, making them easily absorbed and utilized by the body. This bioavailability allows for the efficient delivery of collagen's amino acids and bioactive peptides, which contribute to its health-promoting effects.
Furthermore, scientific research and clinical studies supporting the efficacy and benefits of collagen derivatives in various health areas have also contributed to their increased utilization in nutraceutical applications. As more evidence emerges regarding collagen's positive effects on joint health, skin ageing, and other health conditions, consumer confidence in collagen-based nutraceuticals has grown.
Another factor driving the use of collagen derivatives in the nutraceutical industry is their versatility in the formulation. Collagen derivatives can be easily incorporated into a wide range of nutraceutical products, including capsules, tablets, powders, functional beverages, and bars. This flexibility allows manufacturers to develop innovative and convenient delivery systems for collagen-based supplements, catering to diverse consumer preferences.
The preferred source for collagen derivatives by most manufacturers is driven by its availability, cost-effectiveness, favorable derivative
The bovine market is projected to grow at a CAGR of 7.9% from 2023 to 2033. The market value of the targeted segment is expected to reach US$ 109.16 million by the end of 2033.
Bovine collagen is available at a less cost compared to the other sources. Bovin collagen is found in bovine bone and connective tissue. It is the abundant availability of bovine collagen makes it a cost-effective option for manufacturers as they can produce collagen derivatives at a lower cost and meet the market demand.
It is known for its high collagen content and beneficial amino acid structure. As it has rich in collagen types I and III, the most common types found in human tissue. This similarity in collagen composition makes bovine collagen derivatives highly compatible with human collagen, enhancing their effectiveness and bioavailability when consumed.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Collagen derivatives manufacturers are actively responding to the increasing consumer demand by continuously launching new products. In order to maintain their competitive advantage in the market, companies are implementing a variety of tactics such as celebrity endorsements, advertising, partnerships, collaborations, distribution agreements, and mergers.
For instance:
| Attribute | Details |
|---|---|
| Market Size Value in 2023 | US$ 8,694.1 million |
| Market Forecast Value in 2033 | US$ 15,865.2 million |
| Anticipated Growth Rate (2023 to 2033) | 6.2% CAGR |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | Volume (MT) and Value (US$ Million) |
| Key Regions Covered | Latin America; North America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | Canada, United States, Mexico, Brazil, Chile, Peru, Argentina, Germany, France, Italy, Spain, United Kingdom, Netherlands, Belgium, Nordic, Russia, Poland, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Singapore, Australia, New Zealand, GCC Countries, South Africa, Central Africa, and others |
| Key Market Segments Covered | Source, Dosage Form, Application and Region |
| Key Companies Profiled | Rousselot; PB Collagen; Nippon Collagen; Gelita; Weishardt; PB Gelatin; Nitta Gelatin; Darling Ingredients; Tessenderlo Kerley; Collagen Solutions; BHN; Croda; DSM; Kemira; Innova Flavors |
Increasing preference for nutraceutical supplements boosts India’s market.
The market is estimated to secure a valuation of US$ 8,694.1 million in 2023.
The market is forecast to register a CAGR of 6.2% through 2033.
Increasing interest in sustainable products elevates collagen derivatives in Germany.
Manufacturers are offering innovative and diverse collagen derivatives in the United States.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition
3. Market Dynamics
3.1. Drivers
3.1.1. Supply Side Drivers
3.1.2. Demand Side drivers
3.1.3. Economic Side Drivers
3.2. Restraints
3.3. Opportunity
3.4. Market trends By Region
3.5. Forecast Factors - Relevance & Impact
3.6. Key Regulations and Policies
4. Value Chain Analysis
4.1. Operating margins at each node of the supply chain
4.2. List of Active Market Participants
5. Global - Pricing Analysis
5.1. Price Point Assessment by Region
5.1.1. Manufacturer-Level Pricing
5.1.2. Distributor Level Pricing
5.2. Price Point Assessment by Product
5.3. Price Forecast till 2033
6. Global Market Size (in Value (US$ million) and Volume (MT) Analysis 2018 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Size (in Value (US$ million) and Volume (MT) Analysis, 2018 to 2022
6.2. Current and Future Market Size (in Value (US$ million) and Volume (MT) Analysis, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Source
7.1. Introduction / Key Findings
7.2. Historical Market Size (in Value (US$ million) and Volume (MT) Analysis By Source, 2018 to 2022
7.3. Current and Future Market Size (in Value (US$ million) and Volume (MT) Analysis and Forecast By Source, 2023 to 2033
7.3.1. Bovine
7.3.2. Marine
7.3.3. Porcine
7.4. Market Attractiveness Analysis By Source
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Dosage form
8.1. Introduction / Key Findings
8.2. Historical Market Size (in Value (US$ million) and Volume (MT) Analysis By Dosage form, 2018 to 2022
8.3. Current and Future Market Size (in Value (US$ million) and Volume (MT) Analysis and Forecast By Dosage form, 2023 to 2033
8.3.1. Liquid
8.3.2. Powder
8.4. Market Attractiveness Analysis By Dosage form
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (in Value (US$ million) and Volume (MT) Analysis By Application, 2018 to 2022
9.3. Current and Future Market Size (in Value (US$ million) and Volume (MT) Analysis and Forecast By Application, 2023 to 2033
9.3.1. Food and Beverage
9.3.2. Pharmaceutical
9.3.3. Cosmetics
9.3.4. Nutraceuticals
9.4. Market Attractiveness Analysis By Application
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region
10.1. Introduction
10.2. Historical Market Size (in Value (US$ million) and Volume (MT) Analysis By Region, 2018 to 2022
10.3. Current Market Size (in Value (US$ million) and Volume (MT) Analysis and Forecast By Region, 2023 to 2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East & Africa
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
11.1. Introduction
11.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022
11.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033
11.3.1. By Country
11.3.1.1. USA
11.3.1.2. Canada
11.3.2. By Source
11.3.3. By Dosage form
11.3.4. By Application
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Source
11.4.3. By Dosage form
11.4.4. By Application
11.5. Key Takeaways
12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022
12.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Source
12.3.3. By Dosage form
12.3.4. By Application
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. Source
12.4.3. By Dosage form
12.4.4. By Application
12.5. Key Takeaways
13. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022
13.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. UK
13.3.1.3. France
13.3.1.4. Italy
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Nordic
13.3.1.8. Russia
13.3.1.9. Poland
13.3.1.10. Rest of Europe
13.3.2. By Source
13.3.3. By Dosage form
13.3.4. By Application
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Source
13.4.3. By Dosage form
13.4.4. By Application
13.5. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022
14.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Source
14.3.3. By Dosage form
14.3.4. By Application
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Source
14.4.3. By Dosage form
14.4.4. By Application
14.5. Key Takeaways
15. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022
15.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Malaysia
15.3.1.4. Indonesia
15.3.1.5. Singapore
15.3.1.6. Vietnam
15.3.1.7. Philippines
15.3.1.8. Rest of South Asia
15.3.2. By Source
15.3.3. By Dosage form
15.3.4. By Application
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Source
15.4.3. By Dosage form
15.4.4. By Application
15.5. Key Takeaways
16. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022
16.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Source
16.3.3. By Dosage form
16.3.4. By Application
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Source
16.4.3. By Dosage form
16.4.4. By Application
16.5. Key Takeaways
17. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022
17.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. Egypt
17.3.1.4. South Africa
17.3.1.5. Rest of MEA
17.3.2. By Source
17.3.3. By Dosage form
17.3.4. By Application
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Source
17.4.3. By Dosage form
17.4.4. By Application
17.5. Key Takeaways
18. Country-level Market Analysis, 2022
18.1. US Market Analysis
18.1.1. By Source
18.1.2. By Dosage form
18.1.3. By Application
18.2. Canada Market Analysis
18.2.1. By Source
18.2.2. By Dosage form
18.2.3. By Application
18.3. Brazil Market Analysis
18.3.1. By Source
18.3.2. By Dosage form
18.3.3. By Application
18.4. Mexico Market Analysis
18.4.1. By Source
18.4.2. By Dosage form
18.4.3. By Application
18.5. Argentina Market Analysis
18.5.1. By Source
18.5.2. By Dosage form
18.5.3. By Application
18.6. Germany Market Analysis
18.6.1. By Source
18.6.2. By Dosage form
18.6.3. By Application
18.7. UK Market Analysis
18.7.1. By Source
18.7.2. By Dosage form
18.7.3. By Application
18.8. France Market Analysis
18.8.1. By Source
18.8.2. By Dosage form
18.8.3. By Application
18.9. Italy Market Analysis
18.9.1. By Source
18.9.2. By Dosage form
18.9.3. By Application
18.10. Spain Market Analysis
18.10.1. By Source
18.10.2. By Dosage form
18.10.3. By Application
18.11. Belgium Market Analysis
18.11.1. By Source
18.11.2. By Dosage form
18.11.3. By Application
18.12. Netherlands Market Analysis
18.12.1. By Source
18.12.2. By Dosage form
18.12.3. By Application
18.13. Nordic Market Analysis
18.13.1. By Source
18.13.2. By Dosage form
18.13.3. By Application
18.14. Russia Market Analysis
18.14.1. By Source
18.14.2. By Dosage form
18.14.3. By Application
18.15. Poland Market Analysis
18.15.1. By Source
18.15.2. By Dosage form
18.15.3. By Application
18.16. China Market Analysis
18.16.1. By Source
18.16.2. By Dosage form
18.16.3. By Application
18.17. Japan Market Analysis
18.17.1. By Source
18.17.2. By Dosage form
18.17.3. By Application
18.18. S Korea Market Analysis
18.18.1. By Source
18.18.2. By Dosage form
18.18.3. By Application
18.19. India Market Analysis
18.19.1. By Source
18.19.2. By Dosage form
18.19.3. By Application
18.20. Thailand Market Analysis
18.20.1. By Source
18.20.2. By Dosage form
18.20.3. By Application
18.21. Malaysia Market Analysis
18.21.1. By Source
18.21.2. By Dosage form
18.21.3. By Application
18.22. Vietnam Market Analysis
18.22.1. By Source
18.22.2. By Dosage form
18.22.3. By Application
18.23. Philippines Market Analysis
18.23.1. By Source
18.23.2. By Dosage form
18.23.3. By Application
18.24. Indonesia Market Analysis
18.24.1. By Source
18.24.2. By Dosage form
18.24.3. By Application
18.25. Singapore Market Analysis
18.25.1. By Source
18.25.2. By Dosage form
18.25.3. By Application
18.26. Australia Market Analysis
18.26.1. By Source
18.26.2. By Dosage form
18.26.3. By Application
18.27. New Zealand Market Analysis
18.27.1. By Source
18.27.2. By Dosage form
18.27.3. By Application
18.28. GCC Countries Market Analysis
18.28.1. By Source
18.28.2. By Dosage form
18.28.3. By Application
18.29. Turkey Market Analysis
18.29.1. By Source
18.29.2. By Dosage form
18.29.3. By Application
18.30. Egypt Market Analysis
18.30.1. By Dosage form
18.30.2. By Source
18.30.3. By Application
18.31. South Africa Market Analysis
18.31.1. By Source
18.31.2. By Dosage form
18.31.3. By Application
19. Market Structure Analysis
19.1. Global Competition - a Dashboard View
19.2. Industry Structure Analysis
19.2.1. % tier 1 market players
19.2.2. % tier 2 market players
19.2.3. % tier 3 market players
19.3. Global Market Company Share Analysis
19.3.1. For Tier 1 Market Players, 2023
19.3.2. Company Market Share Analysis of Top 5 Players, By Region
19.4. Key Participants Market Presence (Intensity Mapping) by Region
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Rousselot,
20.3.2. Product Portfolio
20.3.2.1. Product Claim
20.3.2.2. Revenue by Market Segments (Product/ channel/Region)
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.2.4.1. Marketing Strategy
20.3.2.4.2. Product Strategy
20.3.2.4.3. Channel Strategy
20.3.2.4.3.1. SWOT Analysis
20.3.3. Rousselot
20.3.4. Product Portfolio
20.3.4.1. Product Claim
20.3.4.2. Revenue by Market Segments (Product/ channel/Region)
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.4.4.1. Marketing Strategy
20.3.4.4.2. Product Strategy
20.3.4.4.3. Channel Strategy
20.3.4.4.3.1. SWOT Analysis
20.3.5. PB Collagen
20.3.6. Product Portfolio
20.3.6.1. Product Claim
20.3.6.2. Revenue by Market Segments (Product/ channel/Region)
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
20.3.6.4.1. Marketing Strategy
20.3.6.4.2. Product Strategy
20.3.6.4.3. Channel Strategy
20.3.6.4.3.1. SWOT Analysis
20.3.7. Nippon Collagen
20.3.8. Product Portfolio
20.3.8.1. Product Claim
20.3.8.2. Revenue by Market Segments (Product/ channel/Region)
20.3.8.3. Sales Footprint
20.3.8.4. Strategy Overview
20.3.8.4.1. Marketing Strategy
20.3.8.4.2. Product Strategy
20.3.8.4.3. Channel Strategy
20.3.8.4.3.1. SWOT Analysis
20.3.9. Gelita
20.3.10. Product Portfolio
20.3.10.1. Product Claim
20.3.10.2. Revenue by Market Segments (Product/ channel/Region)
20.3.10.3. Sales Footprint
20.3.10.4. Strategy Overview
20.3.10.4.1. Marketing Strategy
20.3.10.4.2. Product Strategy
20.3.10.4.3. Channel Strategy
20.3.10.4.3.1. SWOT Analysis
20.3.11. Weishardt
20.3.12. Product Portfolio
20.3.12.1. Product Claim
20.3.12.2. Revenue by Market Segments (Product/ channel/Region)
20.3.12.3. Sales Footprint
20.3.12.4. Strategy Overview
20.3.12.4.1. Marketing Strategy
20.3.12.4.2. Product Strategy
20.3.12.4.3. Channel Strategy
20.3.12.4.3.1. SWOT Analysis
20.3.13. PB Gelatin
20.3.14. Product Portfolio
20.3.14.1. Product Claim
20.3.14.2. Revenue by Market Segments (Product/ channel/Region)
20.3.14.3. Sales Footprint
20.3.14.4. Strategy Overview
20.3.14.4.1. Marketing Strategy
20.3.14.4.2. Product Strategy
20.3.14.4.3. Channel Strategy
20.3.14.4.3.1. SWOT Analysis
20.3.15. Nitta Gelatin
20.3.16. Product Portfolio
20.3.16.1. Product Claim
20.3.16.2. Revenue by Market Segments (Product/ channel/Region)
20.3.16.3. Sales Footprint
20.3.16.4. Strategy Overview
20.3.16.4.1. Marketing Strategy
20.3.16.4.2. Product Strategy
20.3.16.4.3. Channel Strategy
20.3.16.4.3.1. SWOT Analysis
20.3.17. Darling Ingredients
20.3.18. Product Portfolio
20.3.18.1. Product Claim
20.3.18.2. Revenue by Market Segments (Product/ channel/Region)
20.3.18.3. Sales Footprint
20.3.18.4. Strategy Overview
20.3.18.4.1. Marketing Strategy
20.3.18.4.2. Product Strategy
20.3.18.4.3. Channel Strategy
20.3.18.4.3.1. SWOT Analysis
20.3.19. Tessenderlo Kerley
20.3.20. Product Portfolio
20.3.20.1. Product Claim
20.3.20.2. Revenue by Market Segments (Product/ channel/Region)
20.3.20.3. Sales Footprint
20.3.20.4. Strategy Overview
20.3.20.4.1. Marketing Strategy
20.3.20.4.2. Product Strategy
20.3.20.4.3. Channel Strategy
20.3.20.4.3.1. SWOT Analysis
20.3.21. Collagen Solutions
20.3.22. Product Portfolio
20.3.22.1. Product Claim
20.3.22.2. Revenue by Market Segments (Product/ channel/Region)
20.3.22.3. Sales Footprint
20.3.22.4. Strategy Overview
20.3.22.4.1. Marketing Strategy
20.3.22.4.2. Product Strategy
20.3.22.4.3. Channel Strategy
20.3.22.4.3.1. SWOT Analysis
21. Assumptions and Acronyms Used
22. Research Methodology
Explore Food and Beverage Insights
View Reports
Collagen Derivatives Market
